Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.60004 | 59 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.57365 | 60 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.43971 | 57 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.55019 | 60 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.37648 | 56 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.58475 | 58 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.58983 | 58 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.55977 | 59 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.5608 | 60 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.56152 | 60 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.55749 | 59 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.56721 | 60 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.57265 | 59 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.56111 | 60 |